HCA Announces Special Dividend of $2.00 per Share and Record and Payable Dates

  HCA Announces Special Dividend of $2.00 per Share and Record and Payable

Business Wire

NASHVILLE, Tenn. -- December 06, 2012

HCA Holdings, Inc. (NYSE: HCA) today announced that its Board of Directors has
approved a special cash dividend of $2.00 per share to be paid to shareholders
of record as of December 17, 2012 with a payment date of December 21, 2012.
The dividend is expected to be funded through proceeds from the Company’s
recent offering of $1.0 billion aggregate principal amount of senior notes due

HCA’s ratio of debt-to-Adjusted EBITDA at September30, 2012 was approximately
4.1x compared to 4.5x at December 31, 2011. The Company’s ratio of
debt-to-Adjusted EBITDA is estimated to have been approximately 4.5x on
September 30, 2012 adjusted for financing transactions completed in the fourth
quarter of 2012 and the anticipated impact of the special dividend and
incremental financing.


This press release contains forward-looking statements based on current
management expectations. Those forward-looking statements include all
statements other than those made solely with respect to historical fact,
including statements with respect to the proposed special dividend and related
debt financing. Numerous risks, uncertainties and other factors may cause
actual results to differ materially from those expressed in any
forward-looking statements. These factors include, but are not limited to,
(1)the impact of the special dividend, (2)the impact of our substantial
indebtedness and the ability to refinance such indebtedness on acceptable
terms, (3)the effects related to the enactment and implementation of the
Budget Control Act of 2011 and the outcome of pending government negotiations
related to avoiding the “fiscal cliff” which would result from the BCA’s
automatic spending reductions that include cuts to Medicare payments and tax
increases beginning in federal fiscal year 2013, and the effects related to
cuts to physicians’ Medicare reimbursement if Congress does not override the
scheduled reductions related to the Medicare Sustainable Growth Rate, (4) the
effects related to the enactment and implementation of the Patient Protection
and Affordable Care Act, as amended by the Health Care and Education
Reconciliation Act (collectively, the “Health Reform Law”), the possible
enactment of additional federal or state health care reforms and possible
changes to the Health Reform Law and other federal, state or local laws or
regulations affecting the health care industry, (5)increases in the amount
and risk of collectability of uninsured accounts and deductibles and copayment
amounts for insured accounts, (6)the ability to achieve operating and
financial targets, and attain expected levels of patient volumes and control
the costs of providing services, (7)possible changes in the Medicare,
Medicaid and other state programs, including Medicaid upper payment limit
programs or Waiver Programs, that may impact reimbursements to health care
providers and insurers, (8)the highly competitive nature of the health care
business, (9)changes in service mix, revenue mix and surgical volumes,
including potential declines in the population covered under managed care
agreements, the ability to enter into and renew managed care provider
agreements on acceptable terms and the impact of consumer driven health plans
and physician utilization trends and practices, (10)the efforts of insurers,
health care providers and others to contain health care costs, (11)the
outcome of our continuing efforts to monitor, maintain and comply with
appropriate laws, regulations, policies and procedures, (12)increases in
wages and the ability to attract and retain qualified management and
personnel, including affiliated physicians, nurses and medical and technical
support personnel, (13)the availability and terms of capital to fund the
expansion of our business and improvements to our existing facilities,
(14)changes in accounting practices, (15)changes in general economic
conditions nationally and regionally in our markets, (16)future divestitures
which may result in charges and possible impairments of long-lived assets,
(17)changes in business strategy or development plans, (18)delays in
receiving payments for services provided, (19)the outcome of pending and any
future tax audits, appeals and litigation associated with our tax positions,
(20)potential adverse impact of known and unknown government investigations,
litigation and other claims that may be made against us, (21)our ongoing
ability to demonstrate meaningful use of certified electronic health record
technology and recognize income for the related Medicare or Medicaid incentive
payments, and (22)other risk factors described in our annual report on Form
10-K for the year ended December31, 2011 and our other filings with the
Securities and Exchange Commission. Many of the factors that will determine
our future results are beyond our ability to control or predict. In light of
the significant uncertainties inherent in the forward-looking statements
contained herein, readers should not place undue reliance on forward-looking
statements, which reflect management’s views only as of the date hereof. We
undertake no obligation to revise or update any forward-looking statements, or
to make any other forward-looking statements, whether as a result of new
information, future events or otherwise.

All references to “Company” and “HCA” as used throughout this release refer to
HCA Holdings, Inc. and its affiliates.


HCA Holdings, Inc.
Investor Contact:
Mark Kimbrough, 615-344-2688
Media Contact:
Ed Fishbough, 615-344-2810
Press spacebar to pause and continue. Press esc to stop.